
Experience
MannKind to Acquire scPharmaceuticals for up to $360 Million
August 25, 2025
Cooley advised MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, on its definitive merger agreement to acquire scPharmaceuticals for up to $360 million
Related contacts
Related Practices & Industries
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
August 7, 2025
Cooley advised a syndicate of globally recognized private and public investors in connection with the management-led majority stake acquisition of HistoSonics, the developer of the Edison Histotripsy System and novel histotripsy therapy platform, valuing the company at approximately $2.25 billion.
Related contacts
Related Practices & Industries
Inmagene Biopharmaceuticals Completes Merger With Ikena Oncology [UPDATED]
July 25, 2025
Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).
Related contacts
Related Practices & Industries
Capstan Therapeutics Announces up to $2.1 Billion Acquisition by AbbVie
June 30, 2025
Cooley advised Capstan Therapeutics, a clinical-stage biotechnology company with a mission to multiply therapeutic possibilities for patients through targeted in vivo RNA technologies, on its definitive agreement to be acquired by AbbVie.
Related contacts
Related Practices & Industries
Cooley Advises SoftEye in Sale to TDK
June 19, 2025
Cooley advised SoftEye, a San Diego-based company developing specialized chips, cameras, software and algorithms for use in smart glasses, on its sale to TDK Corporation, a Tokyo-based global leader in advanced electronic solutions designed for a smarter, more connected world.
Related contacts
Related Practices & Industries
Related news and events
US Legal Update, Part Three: Wage and Hour, Pay Equity and Transparency, Contractor Misclassification and More
DOL Issues Proposed Rules Clarifying Contractor Obligations Following Rescission of Executive Order 11246
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
Admissions and credentials
California
Illinois